A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults

MLA

Leroux-Roels, Geert, et al. “A Phase I, Randomized, Controlled, Dose-Ranging Study of Investigational Acellular Pertussis (AP) and Reduced Tetanus-Diphtheria-Acellular Pertussis (TdaP) Booster Vaccines in Adults.” Human Vaccines & Immunotherapeutics, vol. 14, no. 1, Jan. 2018, pp. 45–58. EBSCOhost, https://doi.org/10.1080/21645515.2017.1385686.

APA

Leroux-Roels, G., Lattanzi, M., Solis, C. D., Contorni, M., Costantini, M., Moraschini, L., Bardelli, M., Bertholet, S., Borgogni, E., Buricchi, F., Cantisani, R., Faenzi, E., Finco, O., Leuzzi, R., Pizza, M., Rosa, D., Schiavetti, F., Seubert, A., Spensieri, F., … Galgani, I. (2018). A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults. Human Vaccines & Immunotherapeutics, 14(1), 45–58. https://doi.org/10.1080/21645515.2017.1385686

Chicago

Leroux-Roels, Geert, Maria Lattanzi, Claudia Dovali Solis, Mario Contorni, Marco Costantini, Luca Moraschini, Monia Bardelli, et al. 2018. “A Phase I, Randomized, Controlled, Dose-Ranging Study of Investigational Acellular Pertussis (AP) and Reduced Tetanus-Diphtheria-Acellular Pertussis (TdaP) Booster Vaccines in Adults.” Human Vaccines & Immunotherapeutics 14 (1): 45–58. doi:10.1080/21645515.2017.1385686.